Performance specifications for measurement uncertainty of common biochemical measurands according to Milan models

• Published in: Clinical chemistry and laboratory medicine Vol. 59; no. 8; pp. 1362 - 1368
• Main Authors: Braga, Federica, Panteghini, Mauro
• Format: Journal Article
• Language: English
• Published: Germany De Gruyter 27.07.2021; Walter De Gruyter & Company
• Subjects: Alanine; Alanine transaminase; analytical performance specifications; Bilirubin; Blood; C-reactive protein; Calcium chloride; Creatinine; Hemoglobin; Mathematical analysis; measurement uncertainty; Medical laboratories; metrological traceability; Potassium; Reliability analysis; Specifications; Uncertainty; Urea; measurement uncertainty; analytical performance specifications; metrological traceability
• ISSN: 1434-6621; 1437-4331; 1437-4331
• DOI: 10.1515/cclm-2021-0170

Definition and fullfillment of analytical performance specifications (APS) for measurement uncertainty (MU) allow to make laboratory determinations clinically usable. The 2014 Milan Strategic Conference have proposed models to objectively derive APS based on: (a) the effect of analytical performance on clinical outcome; (b) biological variation components; and (3) the state of the art of the measurement, defined as the highest level of analytical performance technically achievable. Using these models appropriately, we present here a proposal for defining APS for standard MU for some common biochemical measurands. We allocated a group of 13 measurands selected among the most commonly laboratory requested tests to each of the three Milan models on the basis of their biological and clinical characteristics. Both minimum and desirable levels of quality of APS for standard MU of clinical samples were defined by using information obtained from available studies. Blood total hemoglobin, plasma glucose, blood glycated hemoglobin, and serum 25-hydroxyvitamin D3 were allocated to the model 1 and the corresponding desirable APS were 2.80, 2.00, 3.00, and 10.0%, respectively. Plasma potassium, sodium, chloride, total calcium, alanine aminotransferase, creatinine, urea, and total bilirubin were allocated to the model 2 and the corresponding desirable APS were 1.96, 0.27, 0.49, 0.91, 4.65, 2.20, 7.05, and 10.5%, respectively. For C-reactive protein, allocated to the model 3, a desirable MU of 3.76% was defined. APS for MU of clinical samples derived in this study are essential to objectively evaluate the reliability of results provided by medical laboratories.